BiotechTube
Home/MaaT Pharma/Muriel Prudent
MP

Muriel Prudent

Non-Executive Director

MaaT Pharma

Therapeutic Areas

OncologyHematology

MaaT Pharma Pipeline

DrugIndicationPhase
MaaT013Acute Graft-versus-Host Disease (aGvHD)Phase 3
MaaT033Supportive care in Hemato-OncologyPhase 2
MaaT03XSolid Tumors (with ICI)Research

Leadership Team at MaaT Pharma

HA
Hervé Affagard
CEO and Co-founder
CS
Carole Schwintner
Chief Technology Officer
FF
Frédéric Fasano
Chief Strategy & Corporate Development Officer
ES
Eric Soyer
Chief Financial Officer
JL
Jean-Marie Lefevre
Chairman of the Board
DC
Dr. Claude Bertrand
Independent Director
NK
Nadia Kamal
Independent Director
JV
Jean Volatier
Independent Director
ID
Isabelle de Crémoux
Non-Executive Director
DE
Dr. Ernst Holler
Scientific Advisory Board
View full MaaT Pharma profile